{
  "content_taxonomy": [
    "Access",
    "Availability",
    "Brand Awareness and News",
    "Brand Experience",
    "Clinical Trial and Study Info",
    "Clinical Trial Diversity",
    "Clinical Trial Enrollment",
    "Colloquialism",
    "Confirmation",
    "Contractual Terms",
    "Corporate News",
    "Diagnosis",
    "Disease Awareness",
    "Dispense As Written",
    "Dosing",
    "Efficacy",
    "ePermission or Consent or Unsubscribe",
    "Epidemiology",
    "Invitation to Other MCM",
    "Mechanism of Action",
    "Notations",
    "Pathology",
    "Patient Stories",
    "Patient Type",
    "Pfizer Internal Use Only",
    "Product Form Strength Function",
    "Product Label Info",
    "Real World Evidence",
    "Resources HCP",
    "Resources Patient",
    "Safety",
    "Sample",
    "Special Offers and Discounts",
    "Storage and Handling",
    "Summary Messages",
    "Treatment Options",
    "Unmet Need"
  ],
  "medical_affairs_taxonomy": {
    "ContentType": [
      "Scientific Platform",
      "Key Scientific Messages (KSMs)",
      "Medical Information Response (MIRs)",
      "Plain Language Summary (PLS)",
      "Clinical Trial Results Deck",
      "Mechanism of Action (MOA) Deck",
      "Real-World Evidence (RWE) Deck",
      "Health Economics & Outcomes Research (HEOR) Deck",
      "Advisory Board Deck",
      "Regulatory & Labeling Deck"
    ],
    "ClinicalTrialRelevance": [
      "Phase 1 Clinical Trial Data",
      "Phase 2 Clinical Trial Data",
      "Phase 3 Clinical Trial Data",
      "Phase 4/Post-Marketing Surveillance Data",
      "Head-to-Head Trials",
      "Biomarker/Companion Diagnostics Evidence",
      "Meta-Analyses & Systematic Reviews"
    ],
    "DiseaseAndTherapeuticArea": [
      "Oncology",
      "Cardiology",
      "Immunology",
      "Neurology",
      "Rare Diseases",
      "Non-Small Cell Lung Cancer",
      "Crohn's Disease",
      "Multiple Sclerosis"
    ],
    "IntendedAudience": [
      "Internal Medical Affairs",
      "Healthcare Professionals (HCPs)",
      "Payers & Market Access Teams",
      "Regulatory & Compliance Teams",
      "Patients & Advocacy Groups"
    ],
    "KeyScientificMessaging": [
      "Efficacy Data",
      "Safety & Tolerability Profile",
      "Dosing & Administration Guidelines",
      "Real-World Clinical Outcomes",
      "Unmet Medical Need & Differentiation"
    ],
    "DistributionAndAccessControl": [
      "Veeva CRM & MSL Tools",
      "Medical Affairs Internal Repository",
      "Congress Presentations",
      "HCP Portals & Educational Websites",
      "Advisory Board Meetings"
    ],
    "ComplianceAndRegulatoryConsiderations": [
      "Medical Affairs Approved",
      "Internal Use Only",
      "Market-Specific Adaptations (Regional Variations)",
      "Fair Balance Statement",
      "Pre-Approval vs. Post-Approval Use"
    ]
  }
} 